Hippocampal noradrenaline release in awake, freely moving rats is regulated by alpha-2 adrenoceptors but not by adenosine receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 648-654

  Carter, Adrian J ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CLONIDINE; IDAZOXAN; NISOXETINE; NORADRENALIN; POTASSIUM ION; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; CAFFEINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; HIPPOCAMPUS; MALE; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, PURINERGIC P1;

EID: 0031007982     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. ABERCROMBIE, E. D., KELLER, R. W. AND ZIGMOND, M. J.: Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioural studies. Neuroscience 3: 897-904, 1988.
2. +-induced increases in noradrenaline and dopamine release are accompanied by reductions in the release of their intraneuronal metabolites from the rat anterior hypothalamus. An in vivo brain microdialysis study. Arch. Pharmacol. 339: 54-59, 1989.
3. BLÄTTIG, K. AND WELZL, H.: Psychopharmacological profile of caffeine. In Caffeine, Coffee, and Health, ed. by S. Garattini, pp. 213-253, Raven Press Ltd., New York, 1993.
4. BROWN, T. H. AND ZADOR, A. M.: Hippocampus. In The Synaptic Organization of the Brain, ed. by G. M. Shepherd, pp. 346-388, Oxford University Press, Oxford, 1990.
5. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 29: 331-346, 1986.
6. CARTER, A. J.: Microbore high-performance liquid Chromatographic method for the measurement of dopamine and its metabolites: recommendations for optimal sample collection and storage. J. Chromatogr. B 660: 158-163, 1994.
7. 1 receptors. J. Pharmacol. Exp. Ther. 273: 637-642, 1995.
8. CENCI, M. A., KALÉN, P., MANDEL, R. J. AND BJÖRKLUND, A.: Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: A microdialysis study in the rat. Brain Res. 581: 217-228, 1992.
9. CHARNEY, D. S., BREMNER, J. D. AND REDMOND, D. E.: Noradrenergic neural substrates for anxiety and fear. In Psychopharmacology: The Fourth Generation of Progress, ed. by F. E. Bloom and D. J. Kupfer, pp. 387-395, Raven Press Ltd., New York, 1995.
10. CURATOLO, P. W. AND ROBERTSON, D.: The health consequences of caffeine. Ann. Intern. Med. 98: 641-653, 1983.
11. DALY, J. W., BUTTS-LAMB, P. AND PADGETT, W.: Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cell. Mol. Neurobiol. 3: 69-80, 1983.
12. DENNIS, T., L'HEUREUX, R., CARTER, C. AND SCATTON, B.: Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by microdialysis) in the rat. J. Pharmacol. Exp. Ther. 241: 642-649, 1987.
13. European Pharmacopoeia: Council of Europe B.P 907, Strasbourg, 1995.
14. FERRÉ, S., FUXE, K., VON EULER, G., JOHANSSON, B. AND FREDHOLM, B. B.: Adenosine-dopamine interactions in the brain. Neuroscience 51: 501-512, 1992.
15. FERRÉ, S., O'CONNOR, W. T., FUXE, K. AND UNGERSTEDT, U.: The striopallidal neuron: A main locus for adenosine-dopamine interactions in the brain. J. Neurosci. 13: 5402-5406, 1993.
16. FOOTE, S. L. AND ASTON-JONES, G. S.: Pharmacology and physiology of noradrenergic systems. In Psychopharmacology: The Fourth Generation of Progress, ed. by F. E. Bloom and D. J. Kupfer, pp. 335-345, Raven Press Ltd., New York, 1995.
17. FREDHOLM, B. B., JONZON, B. AND LINDGREN, E.: Inhibition of noradrenaline release from hippocampal slices by a stable adenosine analogue. Acta Physiol. Scand. 515: 7-10, 1983.
18. 3H-noradrenaline from slices of rat brain neocortex. Eur. J. Pharmacol. 49: 305-308, 1978.
19. HEUREUX, R. L., DENNIS, T., CURET, O. AND SCATTON, B.: Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: Effects of drugs affecting noradrenergic transmission. J. Neurochem. 46: 1794-1801, 1986.
20. ITOH, Y., OISHI, R., NISHIBORI, M. AND SAEKI, K.: In vivo measurement of noradrenaline and 3,4-dihydroxyphenylethyleneglycol in the rat hypothalamus by microdialysis: Effects of various drugs affecting noradrenaline metabolism. J. Pharmacol. Exp. Ther. 255: 1090-1097, 1990.
21. JACKISCH, R., FEHR, R. AND HERTTING, G.: Adenosine: An endogenous modulator of hippocampal noradrenaline release. Neuropharmacology 24: 499-507, 1985.
22. KALEN, P., ROSEGREN, E., LINDVALL, O. AND BJÖRKLUND, A.: Hippocampal noradrenaline and serotonin release over 24 hours as measured by the dialysis technique in freely moving rats: correlation to behavioural activity state, effect of handling and tail-pinch. Eur. J. Neurosci. 1: 181-188, 1989.
23. 2-adrenoceptors modulating hippocampal norepinephrine release in rat. Brain Res. 674: 238-244, 1995.
24. LI, M. Y., YAN, Q. S., COFFEY, L. L. AND REITH, M. E. A.: Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers. J. Neurochem. 66: 559-568, 1996.
25. LONDOS, C., COOPER, D. M. F. AND WOLF, J.: Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. U.S.A. 77: 2551-2554, 1980.
26. MCCORMICK, D. A. AND WILLIAMSON, A.: Convergence and divergence of neurotransmitter action in human cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 86: 8098-8102, 1989.
27. MOSQUEDA-GARCIA, R., ROBERTSON, D. AND ROBERTSON, R. M.: The cardiovascular effects of caffeine. In Caffeine, Coffee, and Health, ed. by S. Garattini, pp. 157-176, Raven Press Ltd., New York, 1993.
28. NICOLL, R. A.: The coupling of neurotransmitter receptors to ion channels in the brain. Science 241: 545-551, 1988.
29. PELLEGRINO, L. J., PELLEGRINO, A. S. AND CUSHMAN, A. J.: A Stereotaxic Atlas of the Rat Brain, Plenum Press, New York, 1979.
30. RAINNIE, D. G., GRUNZE, H. C. R., MCCARLEY, R. W. AND GREENE, R. W.: Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal. Science 263: 689-692, 1994.
31. RALL, T. W.: Drugs used in the treatment of asthma. The methylxanthines. cromolyn sodium, and other agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed. by A. G. Gilman, T. W. Rall, A. S. Nies and P. Taylor, pp. 618-637, McGraw-Hill Inc., New York, 1993.
32. RICHELSON, E. AND PFENNING, M.: Blockade of antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104: 277-286, 1984.
33. SNYDER, S. H., KATIMS, J. J., ANNAU, Z., BRUNS, R. F. AND DALY, J. W.: Adenosine receptors and behavioral actions of methylxanthines. Proc. Natl. Acad. Sci. U.S.A. 78: 3260-3264, 1981.
34. STARKE, K., GÖTHERT, M. AND KILBINGER, H.: Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev. 69: 864-989, 1989.
35. THOMAS, D. N. AND HOLMAN, R. B.: A microdialysis study of the regulation of endogenous noradrenaline release in the rat hippocampus. J. Neurochem. 56: 1741-1746, 1991.
36. UNGERSTEDT, U.: Introduction to intracerebral dialysis. In Microdialysis in the Neurosciences, ed. by T. E. Robinson and J. B. Justice, pp. 3-22, Elsevier, Amsterdam, 1991.
37. VAN CALKER, D., MÜLLER, M. AND HAMPRECHT, B.: Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33: 999-1005, 1979.
38. VAN VELDHUIZEN, M. J. A., FEENSTRA, M. G. P., BOER, G. J. AND WESTERINK, B. H. C.: Microdialysis studies on cortical noradrenaline release: Basic characteristics, significance of extracellular calcium and massive post-mortem increase. Neurosci. Lett. 119: 233-236, 1990.
39. VAN VELDHUIZEN, M. J. A., FEENSTRA, M. G. P., HEINSBROEK, R. P. W. AND BOER, G. J.: In vivo microdialysis of noradrenaline overflow: Effects of α-adrenoceptor agonists and antagonists measured by cumulative concentration-response curves. Br. J. Pharmacol. 109: 655-660, 1993.
40. VAN VELDHUIZEN, M. J. A., FEENSTRA, M. G. P. AND BOER, G. J.: Regional differences in the in vivo regulation of the extracellular levels of noradrenaline and its metabolites in rat brain. Brain Res. 635: 238-248, 1994.
41. 1-receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 346: 187-196, 1992.
42. WEINER, N. AND MOLINOFF, P. B.: Catecholamines. In Basic Neurochemistry, ed. by G. J. Siegel, B. W. Agranoff, R. W. Albers and P. B. Molinoff, pp. 261-281, Raven Press, New York, 1994.